4.5 Article

Growth arrest in human T-cells is controlled by the non-coding RNA growth-arrest-specific transcript 5 (GAS5)

Journal

JOURNAL OF CELL SCIENCE
Volume 121, Issue 7, Pages 939-946

Publisher

COMPANY BIOLOGISTS LTD
DOI: 10.1242/jcs.024646

Keywords

GAS5; snoRNA; apoptosis; growth arrest; cell cycle; non-coding RNA; autoimmunity; cancer; leukemia

Categories

Funding

  1. Biotechnology and Biological Sciences Research Council [BB/E005896/1] Funding Source: Medline
  2. Wellcome Trust Funding Source: Medline
  3. BBSRC [BB/E005896/1] Funding Source: UKRI
  4. Biotechnology and Biological Sciences Research Council [BB/E005896/1] Funding Source: researchfish

Ask authors/readers for more resources

The control of growth of lymphocyte populations is crucial to the physiological regulation of the immune system, and to the prevention of both leukaemic and autoimmune disease. This control is mediated through modulation of the cell cycle and regulation of cell death. During log-phase growth the rate of proliferation is high and there is a low rate of cell death. As the population density increases, the cell cycle is extended and apoptosis becomes more frequent as the population enters growth arrest. Here, we show that growth-arrest-specific transcript 5 (GAS5) plays an essential role in normal growth arrest in both T-cell lines and non-transformed lymphocytes. Overexpression of GAS5 causes both an increase in apoptosis and a reduction in the rate of progression through the cell-cycle. Consistent with this, down-regulation of endogenous GAS5 inhibits apoptosis and maintains a more rapid cell cycle, indicating that GAS5 expression is both necessary and sufficient for normal growth arrest in T-cell lines as well as human peripheral blood T-cells. Control of apoptosis and the cell cycle by GAS5 has significant consequences for disease pathogenesis, because independent studies have already identified GAS5 as an important candidate gene in the development of autoimmune disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available